Evaluating New 3-D Systems for Disease Modeling, Drug Discovery, and Toxicology from thescientistllc on Vimeo.

Cell and tissue-based models are a necessary step in the workflow for toxicology testing, drug discovery, and disease modeling. In recent years, the research and pharmaceutical industries have adopted more-complex ex vivo and in vitro 3-D tissue models because of their better predictive power. In this webinar, representatives from Bio-Techne will discuss the history of cell- and tissue-based model systems for toxicology, drug screening, and disease modeling. They also introduce MimEX™ Tissue Model Systems, a transformative culturing platform that builds upon the physiological and structural advancements of current organoid models by producing 3-D tissue with better accessibility and lower variability. Tune in to learn more about MimEX 3-D Tissue.

Topics to be covered:

  • History of cell and tissue model systems for toxicology and disease modeling
  • Troubleshooting variability in iPSC-based models
  • Advantages and disadvantages of...

Meet the Speakers:

Scott Schachtele, PhD
Product Manager, Stem Cells and Cell Culture
Bio-Techne

 

 

Kevin Flynn, PhD
Scientist, Stem Cell Research and Development
Bio-Techne

 

 

Webinar Sponsored By:

Interested in reading more?

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?